Matthew Wright

Matthew Wright

Genentech, Inc - South San Francisco / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4380858
-
person_outline Matthew Wright's MOST POPULAR ARTICLES
1-) Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent …DJP Pinto, MJ Orwat, S Wang, JM Fevig, ML Quan, E Amparo, J Cacciola, ...Journal of medicinal chemistry 44 (4), 566-578, 20012502001
2-) Rational use of plasma protein and tissue binding data in drug design: miniperspectiveX Liu, M Wright, CECA HopJournal of medicinal chemistry 57 (20), 8238-8248, 20141612014
3-) Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2ML Quan, CD Ellis, AY Liauw, RS Alexander, RM Knabb, G Lam, ...Journal of medicinal chemistry 42 (15), 2760-2773, 19991301999
4-) Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulantsPYS Lam, CG Clark, R Li, DJP Pinto, MJ Orwat, RA Galemmo, JM Fevig, ...Journal of medicinal chemistry 46 (21), 4405-4418, 20031232003
5-) Isoxazolines and isoxazoles as factor Xa inhibitorsJR Pruitt, DJ Pinto, MJ Estrella, LL Bostrom, RM Knabb, PC Wong, ...Bioorganic & medicinal chemistry letters 10 (8), 685-689, 20001032000